Fabakary Jatta
Ask VT AI
View News Summary
- FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
- Sinner and Alcaraz set for Wimbledon final rematch after Sinner's win over Djokovic.
- Trump imposes 35% tariff on Canadian imports, citing retaliation and fentanyl concerns, as part of broader trade agenda targeting multiple countries.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- FDA rejects Capricor's cell therapy for Duchenne cardiomyopathy, citing insufficient evidence, but the company plans to resubmit with new trial data.
- Sinner and Alcaraz set for Wimbledon final rematch after Sinner's win over Djokovic.
- Trump imposes 35% tariff on Canadian imports, citing retaliation and fentanyl concerns, as part of broader trade agenda targeting multiple countries.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Fabakary Jatta
News from Fabakary Jatta